5-(4-ethoxy-phenyl)-valeric acid ethyl ester | 854659-02-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 5-(4-ethoxy-phenyl)-valeric acid ethyl ester
• 英文别名: 5-(4-Aethoxy-phenyl)-valeriansaeure-aethylester；Ethyl 5-(4-ethoxyphenyl)pentanoate
• CAS: 854659-02-2
• 化学式: C₁₅H₂₂O₃
• 分子量: 250.338
• InChiKey: FAIZNSMKHDPQMB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  18
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-(4-ethoxy-phenyl)-valeric acid ethyl ester 在 sodium 、 三溴化磷 、 Petroleum ether 、 正丁醇 、 苯 作用下， 生成 4-(5-bromo-pentyl)-phenetole
  参考文献：
  名称：

  Experimental Study of Factors That Affect Thermal Comfort in an Upward-Displacement Air-Conditioned Room

  摘要：

  Experiments were carried out to determine the effect of an underfloor air-conditioning system on comfort. The four factors evaluated were the type of outlet, the distance between the outlet and the occupant, the velocity of the supply air, and the temperature of supply air. It was found that the distance between occupant and outlet has a significant influence on thermal comfort, the velocity and temperature of the supply air have a moderate influence, and the ore of outlet has little influence. Recommended values of these factors were developed that would achieve thermal comfort. The results provide reference data on air distribution in underfloor air-conditioned rooms.

  DOI：

  10.1080/10789669.2002.10391436
• 作为产物：
  描述：

  5-(4-乙氧基苯基)-5-氧代戊酸 在 盐酸 、 amalgamated zinc 、 乙醇 、 硫酸 作用下， 生成 5-(4-ethoxy-phenyl)-valeric acid ethyl ester
  参考文献：
  名称：

  Experimental Study of Factors That Affect Thermal Comfort in an Upward-Displacement Air-Conditioned Room

  摘要：

  Experiments were carried out to determine the effect of an underfloor air-conditioning system on comfort. The four factors evaluated were the type of outlet, the distance between the outlet and the occupant, the velocity of the supply air, and the temperature of supply air. It was found that the distance between occupant and outlet has a significant influence on thermal comfort, the velocity and temperature of the supply air have a moderate influence, and the ore of outlet has little influence. Recommended values of these factors were developed that would achieve thermal comfort. The results provide reference data on air distribution in underfloor air-conditioned rooms.

  DOI：

  10.1080/10789669.2002.10391436

文献信息

• PERFLUOROKETONE COMPOUNDS AND USES THEREOF
  申请人：David Samuel

  公开号：US20100048727A1

  公开（公告）日：2010-02-25

  Novel perfluoroketone compounds of formula [I] and [Ia] are described. Also described are uses thereof, such as for inhibition of phospholipase A 2 activity. Therapeutic uses thereof are also described, such as for the treatment of neural conditions and/or inflammatory conditions, such as demyelinating (e.g., multiple sclerosis) and neural injury (e.g., spinal cord injury).

  本文描述了化学式[I]和[Ia]的新型全氟酮化合物。还描述了它们的用途，例如用于抑制磷脂酶A2活性。还描述了它们的治疗用途，例如用于治疗神经疾病和/或炎症疾病，如脱髓鞘（例如多发性硬化症）和神经损伤（例如脊髓损伤）。
• PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
  申请人：TAISHO PHARMACEUTICAL CO., LTD

  公开号：US20150175541A1

  公开（公告）日：2015-06-25

  There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I′): (in the above-mentioned general formula (I′), W, Y, R 2 , R 3 , R 4 , and Y 4 are as described hereinabove), or pharmaceutically acceptable salts thereof.

  提供了一些化合物，具有优越的PHD2抑制作用，其通式表示为(I'):(在上述通式(I')中，W、Y、R2、R3、R4和Y4如上所述)，或其药学上可接受的盐。
• COMPOUND
  申请人：Kokotos George

  公开号：US20110136879A1

  公开（公告）日：2011-06-09

  The invention provides compounds of formula (I) wherein X is O or S; R 1 is H, OH, SH, nitro, NH 2 , NHC 1-6 alkyl, N(C 1-6 alkyl) 2 , halo, haloC 1-6 alkyl, CN, C 1-6 -alkyl, OC 1-6 alkyl, C 1-6 alkylCOOH, C 1-6 alkylCOOC 1-6 alkyl, C 2-6 -alkenyl, C 3-10 cycloalkyl, C 6-10 aryl, C 1-6 alkylC 6-10 aryl, heterocyclyl, heteroaryl, CONH 2 , CONHC 1-6 alkyl, CON(C 1-6 alkyl) 2 , OCOC 1-6 alkyl, or is an acidic group, such as a group comprising a carboxyl, phosphate, phosphinate, sulfate, sulfonate, or tetrazolyl group; R 2 is as defined for R 1 or R 1 and R 2 taken together can form a 6-membered aromatic ring optionally substituted by up to 4 groups R 5 ; R 3 is H, halo (preferably fluoro), or CHal 3 (preferably CF 3 ), each R 5 is defined as for R 1 ; V 1 is a covalent bond or a C 1-20 alkyl group, or C 2-20 -mono or multiply unsaturated alkenyl group; said alkyl or alkenyl groups being optionally interupted by one or more heteroatoms selected from O, NH, N(C 1-6 alkyl), S, SO, or SO 2 ; M 1 is absent or is a C 5-10 cyclic group or a C 5-15 aromatic group; and R 4 is H, halo, OH, CN, nitro, NH 2 , NHC 1-6 alkyl, N(C 1-6 alkyl) 2 , haloC 1-6 alkyl, a C 1-20 alkyl group, or C 2-20 -mono or multiply unsaturated alkenyl group, said C 1-20 alkyl or C 2-20 alkenyl groups being optionally interupted by one or more heteroatoms selected from O, NH, N(C 1-6 alkyl), S, SO, or SO 2 ; with the proviso that the group V 1 M 1 R 4 as a whole provides at least 4 backbone atoms from the C(R 3 ) group; or a salt, ester, solvate, N-oxide, or prodrug thereof; for use in the treatment of a chronic inflammatory condition.
• US9422240B2
  申请人：——

  公开号：US9422240B2

  公开（公告）日：2016-08-23
• US9597318B2
  申请人：——

  公开号：US9597318B2

  公开（公告）日：2017-03-21